CD79A and enteritis: There were no significant differences between CVID-IgA and CVID+IgA in the prevalence of GLILD (p = 0.691), other granulomatous disease (p = 0.569), enteritis (p = 0.169), and malignancy (p = 0.637) in this cohort.